3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Ifosfamide
10
Carboplatin
8
Paclitaxel
7
Etoposide
7
Filgrastim
5
Dexamethasone
3
Cisplatin
3
Thiotepa
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Ondansetron
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Cyclophosphamide
2
Calcium Dobesilate
2
Bleomycin
2
Aprepitant
2
tremelimumab
1
thymoglobulin
1
sodium thiosulfate
1
poly ICLC
1
pembrolizumab
1
pegfilgrastim
1
palifosfamide lysine
1
palbociclib
1
isophosphamide mustard
1
fosaprepitant
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Testicular Neoplasms
×
tipifarnib
×
Clear all
No trials found.